93 related articles for article (PubMed ID: 20356556)
1. [Analysis of safety and effects on the oral whole cell/recombinant B subunit cholera vaccine in university students and workers].
Shi NM; Luo FJ; Li SM; Bai YH; Qu Y; Song X
Zhonghua Yi Xue Za Zhi; 2010 Jan; 90(3):192-5. PubMed ID: 20356556
[TBL] [Abstract][Full Text] [Related]
2. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
Concha A; Giraldo A; Castañeda E; Martínez M; de la Hoz F; Rivas F; Depetris A; Svennerholm AM; Sack DA
Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
[TBL] [Abstract][Full Text] [Related]
3. Investigations into the safety and immunogenicity of a killed oral cholera vaccine developed in Viet Nam.
Trach DD; Cam PD; Ke NT; Rao MR; Dinh D; Hang PV; Hung NV; Canh DG; Thiem VD; Naficy A; Ivanoff B; Svennerholm AM; Holmgren J; Clemens JD
Bull World Health Organ; 2002; 80(1):2-8. PubMed ID: 11884967
[TBL] [Abstract][Full Text] [Related]
4. [Community trial for safety and immunogenicity of oral-administered lyophilized rBS-WC cholera vaccine].
Chen Q; Yu S; Wang Y
Zhonghua Yu Fang Yi Xue Za Zhi; 1996 Nov; 30(6):330-3. PubMed ID: 9388905
[TBL] [Abstract][Full Text] [Related]
5. Reduction of travellers' diarrhoea by WC/rBS oral cholera vaccine in young, high-risk travellers.
Torrell JM; Aumatell CM; Ramos SM; Mestre LG; Salas CM
Vaccine; 2009 Jun; 27(30):4074-7. PubMed ID: 19376179
[TBL] [Abstract][Full Text] [Related]
6. Current status of an oral B subunit whole cell cholera vaccine.
Svennerholm AM; Jertborn M; Gothefors L; Karim A; Sack DA; Holmgren J
Dev Biol Stand; 1983; 53():73-9. PubMed ID: 6873479
[TBL] [Abstract][Full Text] [Related]
7. Safety and immunogenicity of an oral recombinant cholera B subunit-whole cell vaccine in Swedish volunteers.
Jertborn M; Svennerholm AM; Holmgren J
Vaccine; 1992; 10(2):130-2. PubMed ID: 1539466
[TBL] [Abstract][Full Text] [Related]
8. [Study on the immunogenicity and safety of recombinant B-subunit/whole cell cholera vaccine infused with antacids in healthy population at ages of 2-6 years].
Huang T; Li RC; Liu DP
Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Sep; 51(9):827-831. PubMed ID: 28881549
[No Abstract] [Full Text] [Related]
9. Construction and preclinical evaluation of recombinant Peru-15 expressing high levels of the cholera toxin B subunit as a vaccine against enterotoxigenic Escherichia coli.
Roland KL; Cloninger C; Kochi SK; Thomas LJ; Tinge SA; Rouskey C; Killeen KP
Vaccine; 2007 Dec; 25(51):8574-84. PubMed ID: 18045752
[TBL] [Abstract][Full Text] [Related]
10. [A safety assessment on adverse reaction of recombinant B-subunit/inactivated whole cell oral cholera vaccine among non-infected population].
Zhang XP; Chen EF; Lv HK
Zhongguo Yi Miao He Mian Yi; 2009 Jun; 15(3):255-8. PubMed ID: 20084896
[TBL] [Abstract][Full Text] [Related]
11. Randomized, double-blind, placebo-controlled trial to evaluate the safety and immunogenicity of live oral cholera vaccine 638 in Cuban adults.
Valera R; García HM; Jidy MD; Mirabal M; Armesto MI; Fando R; García L; Fernández R; Año G; Cedré B; Ramírez M; Bravo L; Serrano T; Palma S; González D; Miralles F; Medina V; Nuñez F; Plasencia Y; Martínez JC; Mandarioti A; Lugones J; Rodríguez BL; Moreno A; González D; Baro M; Solis RL; Sierra G; Barbera R; Domínguez F; Gutiérrez C; Kouri G; Campa C; Menéndez J
Vaccine; 2009 Nov; 27(47):6564-9. PubMed ID: 19720365
[TBL] [Abstract][Full Text] [Related]
12. Current status of cholera and rise of novel mucosal vaccine.
Yamamoto T
Jpn J Infect Dis; 2000 Oct; 53(5):181-8. PubMed ID: 11135702
[TBL] [Abstract][Full Text] [Related]
13. Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.
Shamsuzzaman S; Ahmed T; Mannoor K; Begum YA; Bardhan PK; Sack RB; Sack DA; Svennerholm AM; Holmgren J; Qadri F
Vaccine; 2009 Feb; 27(9):1386-92. PubMed ID: 19146897
[TBL] [Abstract][Full Text] [Related]
14. Two-year study of the protective efficacy of the oral whole cell plus recombinant B subunit cholera vaccine in Peru.
Taylor DN; Cárdenas V; Sanchez JL; Bégué RE; Gilman R; Bautista C; Perez J; Puga R; Gaillour A; Meza R; Echeverria P; Sadoff J
J Infect Dis; 2000 May; 181(5):1667-73. PubMed ID: 10823767
[TBL] [Abstract][Full Text] [Related]
15. Safety and immunogenicity of the oral, whole cell/recombinant B subunit cholera vaccine in North American volunteers.
Sanchez JL; Trofa AF; Taylor DN; Kuschner RA; DeFraites RF; Craig SC; Rao MR; Clemens JD; Svennerholm AM; Sadoff JC
J Infect Dis; 1993 Jun; 167(6):1446-9. PubMed ID: 8501336
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of mass oral cholera vaccination in Beira, Mozambique.
Lucas ME; Deen JL; von Seidlein L; Wang XY; Ampuero J; Puri M; Ali M; Ansaruzzaman M; Amos J; Macuamule A; Cavailler P; Guerin PJ; Mahoudeau C; Kahozi-Sangwa P; Chaignat CL; Barreto A; Songane FF; Clemens JD
N Engl J Med; 2005 Feb; 352(8):757-67. PubMed ID: 15728808
[TBL] [Abstract][Full Text] [Related]
17. Community-based assessment of safety and immunogenicity of the whole cell plus recombinant B subunit (WC/rBS) oral cholera vaccine in Peru.
Begue RE; Castellares G; Ruiz R; Hayashi KE; Sanchez JL; Gotuzzo E; Oberst RB; Taylor DN; Svennerholm AM
Vaccine; 1995 May; 13(7):691-4. PubMed ID: 7668039
[TBL] [Abstract][Full Text] [Related]
18. Dynamics of intestinal flora after oral vaccination with inactivated whole-cell/recombinant B subunit O139 cholera vaccine.
Wu HX; Chen Q; Li JD; Huang XF
Di Yi Jun Yi Da Xue Xue Bao; 2004 Feb; 24(2):220-2, 225. PubMed ID: 14965834
[TBL] [Abstract][Full Text] [Related]
19. Randomized placebo controlled human volunteer trial of a live oral cholera vaccine VA1.3 for safety and immune response.
Mahalanabis D; Ramamurthy T; Nair GB; Ghosh A; Shaikh S; Sen B; Thungapathra M; Ghosh RK; Pazhani GP; Nandy RK; Jana S; Bhattacharya SK
Vaccine; 2009 Jul; 27(35):4850-6. PubMed ID: 19523608
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of oral cholera vaccine in a stable refugee population at risk for epidemic cholera and in a population with endemic cholera.
Murray J; McFarland DA; Waldman RJ
Bull World Health Organ; 1998; 76(4):343-52. PubMed ID: 9803585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
